Piroxicam
پیروکسیکام
🦴 Musculo-Skeletal SystemNSAID
Market / country: 🇺🇸 USA
Feldene (US)
🧮 Dose calculator
Osteoarthritis · Regimen source: FDA Piroxicam · 2
- • The daily dose may be divided. Steady state after 7–12 days. FDA Piroxicam · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity; history of asthma, urticaria or allergic reaction to aspirin or NSAIDs; perioperative pain in CABG. FDA Piroxicam · 4
Warnings
- • Boxed warning: risk of serious thrombotic cardiovascular events and GI bleeding, ulceration and perforation. FDA Piroxicam · Boxed Warning
Formulations
- 10 mg capsule — capsule 🇺🇸 USA FDA Piroxicam · 3
- 20 mg capsule — capsule 🇺🇸 USA FDA Piroxicam · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Piroxicam · 8.1
“Clinical Considerations Fetal/Neonatal Adverse Reactions Premature Closure of Fetal Ductus Arteriosus: Avoid use of NSAIDs in women at about 30 weeks gestation and later in pregnancy, because NSAIDs, including piroxicam, can cause premature closure of the fetal ductus arteriosus ( see Data ).”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Piroxicam · 8.2
“Risk Summary Limited data from 2 published reports that included a total of 6 breastfeeding women and 2 infants showed piroxicam is excreted in human milk at approximately 1% to 3% of the maternal concentration.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Piroxicam · 8.4
“Piroxicam has not been investigated in pediatric patients.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Piroxicam · Boxed Warning
“Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events [see Warnings and Precautions ( 5.2 )] .”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Piroxicam · 8.3
“Infertility Females Based on the mechanism of action, the use of prostaglandin-mediated NSAIDs, including piroxicam, may delay or prevent rupture of ovarian follicles, which has been associated with reversible infertility in some women.”
🔗 Reference links
- FDA (approval record)ANDA074131
- DailyMed (FDA label)FDA Piroxicam
- MedlinePlus (NIH)Piroxicam
- WHO ATC/DDDM01AC01
- Darooyab (Iran)Piroxicam
🇮🇷 Registered in Iran Darooyab · G-171/Piroxicam
Dosage forms with Iranian generic codes, per Darooyab.
- 01016 · PIROXICAM 0.5% GEL · ژل پیروکسیکام ۰٫۵ درصد
- 01017 · PIROXICAM 10MG CAP · کپسول پیروکسیکام ۱۰ میلیگرم
- 02094 · PIROXICAM 20MG SUPP · شیاف پیروکسیکام ۲۰ میلیگرم
- 01018 · PIROXICAM 20MG/1ML AMP · آمپول پیروکسیکام ۲۰ میلیگرم / ۱ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Piroxicam · 3FDA Piroxicam · 2FDA Piroxicam · 4FDA Piroxicam · Boxed WarningFDA Piroxicam · SPL approval / marketing categoryFDA Piroxicam · 8.1FDA Piroxicam · 8.2FDA Piroxicam · 8.4FDA Piroxicam · 8.3
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-171/Piroxicam
- Clinical review⚠ Unverified